TY - JOUR
T1 - Nanodelivery of nucleic acids
AU - Mendes, Bárbara B.
AU - Conniot, João
AU - Avital, Aviram
AU - Yao, Dongbao
AU - Jiang, Xingya
AU - Zhou, Xiang
AU - Sharf-Pauker, Noga
AU - Xiao, Yuling
AU - Adir, Omer
AU - Liang, Haojun
AU - Shi, Jinjun
AU - Schroeder, Avi
AU - Conde, João
N1 - Publisher Copyright:
© 2022, Springer Nature Limited.
PY - 2022/12/1
Y1 - 2022/12/1
N2 - There is growing need for a safe, efficient, specific and non-pathogenic means for delivery of gene therapy materials. Nanomaterials for nucleic acid delivery offer an unprecedented opportunity to overcome these drawbacks; owing to their tunability with diverse physico-chemical properties, they can readily be functionalized with any type of biomolecules/moieties for selective targeting. Nucleic acid therapeutics such as antisense DNA, mRNA, small interfering RNA (siRNA) or microRNA (miRNA) have been widely explored to modulate DNA or RNA expression Strikingly, gene therapies combined with nanoscale delivery systems have broadened the therapeutic and biomedical applications of these molecules, such as bioanalysis, gene silencing, protein replacement and vaccines. Here, we overview how to design smart nucleic acid delivery methods, which provide functionality and efficacy in the layout of molecular diagnostics and therapeutic systems. It is crucial to outline some of the general design considerations of nucleic acid delivery nanoparticles, their extraordinary properties and the structure–function relationships of these nanomaterials with biological systems and diseased cells and tissues.
AB - There is growing need for a safe, efficient, specific and non-pathogenic means for delivery of gene therapy materials. Nanomaterials for nucleic acid delivery offer an unprecedented opportunity to overcome these drawbacks; owing to their tunability with diverse physico-chemical properties, they can readily be functionalized with any type of biomolecules/moieties for selective targeting. Nucleic acid therapeutics such as antisense DNA, mRNA, small interfering RNA (siRNA) or microRNA (miRNA) have been widely explored to modulate DNA or RNA expression Strikingly, gene therapies combined with nanoscale delivery systems have broadened the therapeutic and biomedical applications of these molecules, such as bioanalysis, gene silencing, protein replacement and vaccines. Here, we overview how to design smart nucleic acid delivery methods, which provide functionality and efficacy in the layout of molecular diagnostics and therapeutic systems. It is crucial to outline some of the general design considerations of nucleic acid delivery nanoparticles, their extraordinary properties and the structure–function relationships of these nanomaterials with biological systems and diseased cells and tissues.
UR - https://www.scopus.com/pages/publications/85130308295
U2 - 10.1038/s43586-022-00104-y
DO - 10.1038/s43586-022-00104-y
M3 - Review article
AN - SCOPUS:85130308295
SN - 2662-8449
VL - 2
JO - Nature Reviews Methods Primers
JF - Nature Reviews Methods Primers
IS - 1
M1 - 24
ER -